Taysha Gene Therapies Inc (NAS:TSHA)
$ 3.97 -0.2 (-4.8%) Market Cap: 742.46 Mil Enterprise Value: 716.59 Mil PE Ratio: 0 PB Ratio: 13.69 GF Score: 29/100

Taysha Gene Therapies Inc (TSHA) Transcripts

  • 1